tetano
Editor, Senior Moderator
J Matern Fetal Neonatal Med
. 2024 Dec;37(1):2345852.
doi: 10.1080/14767058.2024.2345852. Epub 2024 May 26. COVID-19 is associated with early emergence of preeclampsia: results from a large regional collaborative
Yasmin G Hasbini[SUP] 1 [/SUP], Robert J Sokol[SUP] 2 3 [/SUP], Pooja M Green[SUP] 4 [/SUP], Adi L Tarca[SUP] 5 6 [/SUP], Gregory Goyert[SUP] 7 [/SUP], Hala M El Ouweini[SUP] 1 [/SUP], Madhurima Keerthy[SUP] 7 [/SUP], Theodore Jones[SUP] 8 [/SUP], Lisa Thiel[SUP] 9 [/SUP], Youssef Youssef[SUP] 10 [/SUP], Courtney Townsel[SUP] 11 [/SUP], Shyla Vengalil[SUP] 12 [/SUP], Paige Paladino[SUP] 13 [/SUP], Amy Wright[SUP] 14 [/SUP], Mariam Ayyash[SUP] 7 [/SUP], Gayathri Vadlamudi[SUP] 7 [/SUP], Marta Szymanska[SUP] 15 [/SUP], Sonia Sajja[SUP] 15 [/SUP], Grace Crane[SUP] 9 [/SUP], Michael Baracy Jr[SUP] 12 [/SUP], Karlee Grace[SUP] 13 [/SUP], Kaitlyn Houston[SUP] 11 [/SUP], Jessica Norman[SUP] 14 [/SUP], Kathleen Girdler[SUP] 1 [/SUP], Dereje W Gudicha[SUP] 4 [/SUP], Ray Bahado-Singh[SUP] 15 [/SUP], Sonia S Hassan[SUP] 1 2 [/SUP]
Affiliations
Objective: To investigate the relationship between preeclampsia and SARS-CoV-2 infection during pregnancy. Methods: This was a retrospective cohort study of pregnant women between March and October 2020. Pregnant patients admitted to 14 obstetrical centers in Michigan, USA formed the study population. Of the N = 1458 participants, 369 had SARS-CoV-2 infection (cases). Controls were uninfected pregnancies that were delivered in the same obstetric unit within 30 days of the index case. Robust Poisson regression was used to estimate relative risk (RR) of preterm and term preeclampsia and preeclampsia involving placental lesions. The analysis included adjustment for relevant clinical and demographic risk factors.Results: SARS-CoV-2 infection during pregnancy increased the risk of preeclampsia [adjusted aRR = 1.69 (1.26-2.26)], preeclampsia involving placental lesions [aRR = 1.97(1.14-3.4)] and preterm preeclampsia 2.48(1.48-4.17). Although the highest rate of preeclampsia was observed in patients infected with SARS-CoV-2 who were symptomatic (18.4%), there was increased risk even in asymptomatic SARS-CoV-2 infected patients (14.2%) relative to non-infected controls (8.7%) (p < 0.05). This association with symptomatology was also noted with preterm preeclampsia for which the rate doubled from 2.7% in controls to 5.2% in asymptomatic cases and reached 11.8% among symptomatic cases (p < 0.05). The rate of preterm preeclampsia among cases of pregnant people self-identified as Black reached 10.1% and was almost double the rate of the reminder of the group of infected pregnancies (5.3%), although the rate among uninfected was almost the same (2.7%) for both Black and non-Black groups (interaction p = 0.05).Conclusions: Infection with SARS-CoV-2 increases the risk of preeclampsia even in the absence of symptoms, although symptomatic persons are at even higher risk. Racial disparities in the development of preterm preeclampsia after SARS-CoV-2 infection may explain discrepancies in prematurity between different populations.
Keywords: Coronavirus disease 2019 (COVID-19); maternal morbidity; preeclampsia; pregnancy; preterm birth; racial disparities.
. 2024 Dec;37(1):2345852.
doi: 10.1080/14767058.2024.2345852. Epub 2024 May 26. COVID-19 is associated with early emergence of preeclampsia: results from a large regional collaborative
Yasmin G Hasbini[SUP] 1 [/SUP], Robert J Sokol[SUP] 2 3 [/SUP], Pooja M Green[SUP] 4 [/SUP], Adi L Tarca[SUP] 5 6 [/SUP], Gregory Goyert[SUP] 7 [/SUP], Hala M El Ouweini[SUP] 1 [/SUP], Madhurima Keerthy[SUP] 7 [/SUP], Theodore Jones[SUP] 8 [/SUP], Lisa Thiel[SUP] 9 [/SUP], Youssef Youssef[SUP] 10 [/SUP], Courtney Townsel[SUP] 11 [/SUP], Shyla Vengalil[SUP] 12 [/SUP], Paige Paladino[SUP] 13 [/SUP], Amy Wright[SUP] 14 [/SUP], Mariam Ayyash[SUP] 7 [/SUP], Gayathri Vadlamudi[SUP] 7 [/SUP], Marta Szymanska[SUP] 15 [/SUP], Sonia Sajja[SUP] 15 [/SUP], Grace Crane[SUP] 9 [/SUP], Michael Baracy Jr[SUP] 12 [/SUP], Karlee Grace[SUP] 13 [/SUP], Kaitlyn Houston[SUP] 11 [/SUP], Jessica Norman[SUP] 14 [/SUP], Kathleen Girdler[SUP] 1 [/SUP], Dereje W Gudicha[SUP] 4 [/SUP], Ray Bahado-Singh[SUP] 15 [/SUP], Sonia S Hassan[SUP] 1 2 [/SUP]
Affiliations
- PMID: 38797682
- DOI: 10.1080/14767058.2024.2345852
Objective: To investigate the relationship between preeclampsia and SARS-CoV-2 infection during pregnancy. Methods: This was a retrospective cohort study of pregnant women between March and October 2020. Pregnant patients admitted to 14 obstetrical centers in Michigan, USA formed the study population. Of the N = 1458 participants, 369 had SARS-CoV-2 infection (cases). Controls were uninfected pregnancies that were delivered in the same obstetric unit within 30 days of the index case. Robust Poisson regression was used to estimate relative risk (RR) of preterm and term preeclampsia and preeclampsia involving placental lesions. The analysis included adjustment for relevant clinical and demographic risk factors.Results: SARS-CoV-2 infection during pregnancy increased the risk of preeclampsia [adjusted aRR = 1.69 (1.26-2.26)], preeclampsia involving placental lesions [aRR = 1.97(1.14-3.4)] and preterm preeclampsia 2.48(1.48-4.17). Although the highest rate of preeclampsia was observed in patients infected with SARS-CoV-2 who were symptomatic (18.4%), there was increased risk even in asymptomatic SARS-CoV-2 infected patients (14.2%) relative to non-infected controls (8.7%) (p < 0.05). This association with symptomatology was also noted with preterm preeclampsia for which the rate doubled from 2.7% in controls to 5.2% in asymptomatic cases and reached 11.8% among symptomatic cases (p < 0.05). The rate of preterm preeclampsia among cases of pregnant people self-identified as Black reached 10.1% and was almost double the rate of the reminder of the group of infected pregnancies (5.3%), although the rate among uninfected was almost the same (2.7%) for both Black and non-Black groups (interaction p = 0.05).Conclusions: Infection with SARS-CoV-2 increases the risk of preeclampsia even in the absence of symptoms, although symptomatic persons are at even higher risk. Racial disparities in the development of preterm preeclampsia after SARS-CoV-2 infection may explain discrepancies in prematurity between different populations.
Keywords: Coronavirus disease 2019 (COVID-19); maternal morbidity; preeclampsia; pregnancy; preterm birth; racial disparities.